BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38377560)

  • 1. Discovery of Novel
    Zhang M; Ding Y; Gao M; Lu X; Tan J; Yu F; Gu C; Gu L; Ren X; Hao C; Ming L; Xu K; Mao W; Jin Y; Zhang M; You L; Wang Z; Sun Y; Jiang J; Yang Y; Zhang D; Tang X
    J Med Chem; 2024 Mar; 67(5):3909-3934. PubMed ID: 38377560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis.
    Feng Y; Wang W; Zhang Y; Fu X; Ping K; Zhao J; Lei Y; Mou Y; Wang S
    Eur J Med Chem; 2022 Feb; 229():114070. PubMed ID: 34968902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.
    Li J; Hu X; Luo T; Lu Y; Feng Y; Zhang H; Liu D; Fan X; Wang Y; Jiang L; Wang Y; Hao X; Shi T; Wang Z
    Eur J Med Chem; 2021 Dec; 226():113817. PubMed ID: 34537445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, biological evaluation and molecular docking study of novel urea-based benzamide derivatives as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
    Lu G; Nie W; Xin M; Meng Y; Gu J; Miao H; Cheng X; Chan ASC; Zou Y
    Eur J Med Chem; 2022 Dec; 243():114790. PubMed ID: 36183505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger Protein207 orchestrates glioma migration through regulation of epithelial-mesenchymal transition.
    Zhao C; Guo Y; Chen Y; Shang G; Song D; Wang J; Yang J; Zhang H
    Environ Toxicol; 2024 Apr; ():. PubMed ID: 38591780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
    Lu Y; Feng Y; Li Z; Li J; Zhang H; Hu X; Jiang W; Shi T; Wang Z
    Eur J Med Chem; 2022 Jan; 227():113908. PubMed ID: 34656900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel (E)-N-phenyl-4-(pyridine-acylhydrazone) benzamide derivatives as potential antitumor agents for the treatment of multiple myeloma (MM).
    Li XY; Li S; Lu GQ; Wang DP; Liu KL; Qian XH; Xue WH; Meng FH
    Bioorg Chem; 2020 Oct; 103():104189. PubMed ID: 32890996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule Inhibitors.
    Zhou Y; Zhang L; Fu X; Jiang Z; Tong R; Shi J; Li J; Zhong L
    Chem Biodivers; 2019 Sep; 16(9):e1900304. PubMed ID: 31338947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent.
    Yang H; Zhang D; Yuan Z; Qiao H; Xia Z; Cao F; Lu Y; Jiang F
    Eur J Med Chem; 2024 Mar; 267():116205. PubMed ID: 38350361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of benzamide-based PI3K/HDAC dual inhibitors with marked pro-apoptosis activity in lymphoma cells.
    Deng J; Hou B; Hou X; Chen Y; Zhang T; Chen H; Wang Y; Li X
    Eur J Med Chem; 2023 Dec; 262():115915. PubMed ID: 37948955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel 4-(pyrrolo[2,3-d]pyrimidine-4-yloxy)benzamide derivatives as potential antitumor agents.
    Zhang J; Xiong H; Yang F; He J; Chen T; Fu D; Zheng P; Tang Q
    Bioorg Med Chem Lett; 2021 Feb; 33():127740. PubMed ID: 33316412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel benzamide derivatives bearing benzamidophenyl and phenylacetamidophenyl scaffolds as potential antitumor agents via targeting PARP-1.
    Lu G; Nie W; Xin M; Meng Y; Jiang J; Gu J; Cheng X; Chan ASC; Zou Y
    Eur J Med Chem; 2023 May; 251():115243. PubMed ID: 36921527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models.
    Gretskaya NM; Gamisonia AM; Dudina PV; Zakharov SS; Sherstyanykh G; Akasov R; Burov S; Serkov IV; Akimov MG; Bezuglov VV; Markvicheva E
    Eur J Pharmacol; 2020 Sep; 883():173346. PubMed ID: 32659303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of 4-(pyridin-4-yloxy)benzamide derivatives bearing a 5-methylpyridazin-3(2H)-one fragment.
    Xiong H; Zhang J; Zhang Q; Duan Y; Zhang H; Zheng P; Tang Q
    Bioorg Med Chem Lett; 2020 May; 30(9):127076. PubMed ID: 32173195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo.
    Liu YM; Tu HJ; Wu CH; Lai MJ; Yu SC; Chao MW; Wu YW; Teng CM; Pan SL; Liou JP
    Eur J Med Chem; 2021 Jul; 219():113428. PubMed ID: 33934008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Bioactivity Evaluation of Novel Rosin Diterpenoid Derivatives as Potential Anti-glioma Agents.
    Ou J; Tan W; Chen G; Yang X; Luo Y; Jin X; Ye L
    Chem Biodivers; 2023 Aug; 20(8):e202300942. PubMed ID: 37485637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells.
    Shi L; Gao LL; Cai SZ; Xiong QW; Ma ZR
    Eur J Med Chem; 2021 Oct; 221():113528. PubMed ID: 34020339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways.
    Huang ZN; Liang H; Qiao H; Wang BR; Qu N; Li H; Zhou RR; Wang LJ; Li SH; Li FN
    Arch Pharm Res; 2018 Dec; 41(12):1149-1161. PubMed ID: 29998374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer.
    Xie Z; Cheng D; Luo L; Shen G; Pan S; Pan Y; Chen B; Wang X; Liu Z; Zhang Y; Ye F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):905-919. PubMed ID: 29734851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors.
    Zhang S; Huang W; Li X; Yang Z; Feng B
    Chem Biol Drug Des; 2015 Oct; 86(4):795-804. PubMed ID: 25763653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.